A detailed history of Board Of Trustees Of The Leland Stanford Junior University transactions in Bolt Biotherapeutics, Inc. stock. As of the latest transaction made, Board Of Trustees Of The Leland Stanford Junior University holds 719,546 shares of BOLT stock, worth $453,313. This represents 0.04% of its overall portfolio holdings.

Number of Shares
719,546
Previous 719,546 -0.0%
Holding current value
$453,313
Previous $539,000 13.36%
% of portfolio
0.04%
Previous 0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$0.85 - $1.12 $31,918 - $42,057
-37,551 Reduced 4.96%
719,546 $805,000
Q3 2023

Nov 14, 2023

BUY
$0.98 - $1.46 $36,799 - $54,824
37,551 Added 5.22%
757,097 $787,000
Q2 2021

Aug 16, 2021

BUY
$15.4 - $31.46 $11.1 Million - $22.6 Million
719,546 New
719,546 $11.1 Million

Others Institutions Holding BOLT

About Bolt Biotherapeutics, Inc.


  • Ticker BOLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,641,500
  • Market Cap $23.7M
  • Description
  • Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...
More about BOLT
Track This Portfolio

Track Board Of Trustees Of The Leland Stanford Junior University Portfolio

Follow Board Of Trustees Of The Leland Stanford Junior University and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Board Of Trustees Of The Leland Stanford Junior University, based on Form 13F filings with the SEC.

News

Stay updated on Board Of Trustees Of The Leland Stanford Junior University with notifications on news.